News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Business
Has Gilead Finally Bottomed Out?
May 9, 2017
·
1 min read
Biotech Bay
This New Threat Could Cause Gilead to Hit Bottom
May 5, 2017
·
3 min read
Biotech Bay
Gilead Hints at 5-Point Comeback Strategy
May 4, 2017
·
4 min read
Drug Development
Why Gilead Should Pay Close Attention And Maybe Even Fear Allergan’s NASH Program
April 25, 2017
·
1 min read
Biotech Bay
Gilead: A Future Dividend Gold Mine At A Bargain Price
April 25, 2017
·
1 min read
Business
Gilead’s $600 Million NASH Deal Finally Bears Fruit
April 24, 2017
·
3 min read
Deals
How This Iowa Biotech Could be a Perfect Match for M&A Hungry Gilead
April 24, 2017
·
3 min read
Business
Gilead’s Rumored M&A Target Incyte Doubled CEO’s Pay Package in 2016
April 18, 2017
·
1 min read
Drug Development
How AbbVie, Gilead, Pfizer Are All Gaining From Eli Lilly’s RA Rejection Pain
April 18, 2017
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
December 25, 2025
·
8 min read
Press Releases
Gilead Sciences to Present at Upcoming Investor Conference
December 23, 2025
·
1 min read
Press Releases
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
December 23, 2025
·
8 min read
Press Releases
Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer
December 22, 2025
·
5 min read
Press Releases
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
December 22, 2025
·
5 min read
Press Releases
Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance
December 19, 2025
·
2 min read
Press Releases
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial
December 16, 2025
·
9 min read
Press Releases
Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio
December 15, 2025
·
13 min read
Press Releases
Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer
December 10, 2025
·
4 min read
Press Releases
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes
December 9, 2025
·
19 min read
